LacTEST (gaxilose)
Diagnosis of Lactose Malabsorption (Hypolactasia)
ApprovedCommercial
Key Facts
Indication
Diagnosis of Lactose Malabsorption (Hypolactasia)
Phase
Approved
Status
Commercial
Company
About VenterPharma
VenterPharma is a private, commercial-stage diagnostics company based in Barcelona, Spain, founded in 2015 (with roots dating to 2003). It has developed and commercialized LacTEST, a non-invasive diagnostic drug for lactose malabsorption, along with associated analysis methods (Osaxyl and Xylossay). The company is revenue-generating, with its products financed by the Spanish public health system, and maintains an R&D pipeline targeting other digestive pathologies. Its strategy centers on providing simple, effective, and cost-effective diagnostic solutions for gastroenterology.
View full company profile